HomeMarket News"3 Promising Health Care Stocks Poised for Significant Growth This Quarter"

“3 Promising Health Care Stocks Poised for Significant Growth This Quarter”

Daily Market Recaps (no fluff)

always free

Top Oversold Stocks in Health Care: Opportunities for Bargain Investors

The health care sector is showing signs of undervalued stocks that might be worth considering for investment.

The Relative Strength Index (RSI) is an important momentum indicator that helps traders assess a stock’s performance over time. It compares the days when a stock’s price increases to the days when it decreases. When a stock’s RSI falls below 30, it is typically seen as oversold, signaling a potential buying opportunity, according to Benzinga Pro.

Below is a current list of major health care stocks with an RSI near or below 30, presenting possible investment opportunities.

Viking Therapeutics Inc VKTX

  • On January 17, HC Wainwright & Co. analyst Joseph Pantginis reaffirmed a Buy rating for Viking Therapeutics, setting a price target of $102. Over the last month, the stock declined approximately 22%, reaching a 52-week low of $20.83.
  • RSI Value: 28.8
  • VKTX Price Action: Shares of Viking Therapeutics increased by 0.7%, closing at $32.87 on Tuesday.
  • Benzinga Pro’s real-time newsfeed has reported recent updates on VKTX.
image 138

Radnet Inc RDNT

  • On January 15, Jefferies analyst Brian Tanquilut maintained a Buy rating for RadNet, while lowering the price target from $100 to $80. The stock saw an 11% drop in the past five days and has a 52-week low of $35.16.
  • RSI Value: 25.2
  • ‘;

  • RDNT Price Action: Radnet shares rose by 0.6% to close at $60.19 on Tuesday.
  • Benzinga Pro’s charting tool provided insights into the movement of RDNT stock.
image 139

Vera Therapeutics Inc VERA

  • On January 13, Vera Therapeutics announced it had secured an exclusive license from Stanford University for VT-109, a fusion protein targeting BAFF and APRIL, which may have significant potential in treating B cell-mediated diseases. The company’s stock fell roughly 20% over the past month, reaching a 52-week low of $15.46.
  • RSI Value: 27.2
  • VERA Price Action: Vera Therapeutics’ shares climbed 1%, closing at $33.70 on Tuesday.
  • Benzinga Pro’s analytics indicated a possible breakout for VERA shares.
image 140

Read This Next:

Market News and Data brought to you by Benzinga APIs

Do you want a daily market summary with no fluff?

Simple Straightforward Daily Stock Market Recaps Sent for free,every single trading day: Read Now

Explore More

Simple Straightforward Daily Stock Market Recaps

Get institutional-level analysis to take your trading to the next level, sign up for free and become apart of the community.